New England Journal of Medicine

Papers
(The TQCC of New England Journal of Medicine is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine11797
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine8134
Dexamethasone in Hospitalized Patients with Covid-196981
Remdesivir for the Treatment of Covid-19 — Final Report5468
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report2667
Empagliflozin in Heart Failure with a Preserved Ejection Fraction2546
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant2309
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting2167
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates2126
Cytokine Storm2098
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-192028
Once-Weekly Semaglutide in Adults with Overweight or Obesity1830
Lecanemab in Early Alzheimer’s Disease1801
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant1776
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination1748
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results1746
Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer1712
New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race1674
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-191555
Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months1461
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-191448
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma1393
Monkeypox Virus Infection in Humans across 16 Countries — April–June 20221370
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-191346
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients1332
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes1329
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-191326
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer1284
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure1217
Tirzepatide Once Weekly for the Treatment of Obesity1198
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer1191
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction1188
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults1186
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers1163
Colchicine in Patients with Chronic Coronary Disease1152
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer1146
Severe Covid-191138
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination1131
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months1116
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia1109
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma1098
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host1086
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-191080
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma1076
Remdesivir for 5 or 10 Days in Patients with Severe Covid-191064
Efficacy of Tocilizumab in Patients Hospitalized with Covid-191057
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant1015
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis1006
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia993
Sotorasib for Lung Cancers with KRAS p.G12C Mutation991
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma981
How Structural Racism Works — Racist Policies as a Root Cause of U.S. Racial Health Inequities963
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis961
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer959
Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine958
Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine932
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer917
Empagliflozin in Patients with Chronic Kidney Disease908
Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel887
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients872
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19870
Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab844
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis843
Waning Immunity after the BNT162b2 Vaccine in Israel841
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes839
Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants828
Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine809
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19781
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination774
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma772
PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer770
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting767
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers761
Donanemab in Early Alzheimer’s Disease759
Trial of Psilocybin versus Escitalopram for Depression754
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer749
Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine744
Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients739
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease736
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents729
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia727
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes727
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19717
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults702
Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile690
Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease689
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19680
A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia680
Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons677
Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar668
Pathophysiology of Inflammatory Bowel Diseases666
First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer647
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination641
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine640
Rethinking Covid-19 Test Sensitivity — A Strategy for Containment627
Vaccine Breakthrough Infections with SARS-CoV-2 Variants626
Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women618
Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma607
Racial Bias in Pulse Oximetry Measurement603
Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19600
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer599
Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest594
Acquired Resistance to KRASG12C Inhibition in Cancer591
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer586
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma575
New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications565
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer559
Avacopan for the Treatment of ANCA-Associated Vasculitis551
Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa550
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19550
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes549
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease538
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant534
Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines527
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma522
Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19521
Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma516
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection514
Evidence of Artemisinin-Resistant Malaria in Africa511
Neutralizing Activity of BNT162b2-Elicited Serum511
Diffuse Large B-Cell Lymphoma495
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine495
Trastuzumab Deruxtecan in HER2 -Mutant Non–Small-Cell Lung Cancer494
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer493
Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants493
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma487
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer485
Myocarditis after Covid-19 Vaccination in a Large Health Care Organization483
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19478
Osteoarthritis of the Knee474
Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients472
A Bivalent Omicron-Containing Booster Vaccine against Covid-19470
A Population-Based Study of Genes Previously Implicated in Breast Cancer468
Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel465
Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5463
Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation458
Teclistamab in Relapsed or Refractory Multiple Myeloma451
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma448
Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis447
Endovascular Therapy for Acute Stroke with a Large Ischemic Region445
Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer444
Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer444
Homologous and Heterologous Covid-19 Booster Vaccinations441
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age439
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women437
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer435
Migraine435
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase428
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19427
Race and Genetic Ancestry in Medicine — A Time for Reckoning with Racism425
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression423
Microvascular Injury in the Brains of Patients with Covid-19422
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer416
Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections414
Artificial Intelligence and Machine Learning in Clinical Medicine, 2023412
Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine407
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes406
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure400
100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care — Preliminary Report398
Trends in Diabetes Treatment and Control in U.S. Adults, 1999–2018396
Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia395
Adagrasib in Non–Small-Cell Lung Cancer Harboring a KRAS G12C Mutation395
Endometrial Cancer393
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke391
SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia389
Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines387
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma385
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity385
SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons383
Cryoballoon Ablation as Initial Therapy for Atrial Fibrillation379
Effect of Salt Substitution on Cardiovascular Events and Death377
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension375
Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer375
Protection against the Omicron Variant from Previous SARS-CoV-2 Infection373
Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings368
Trial of Endovascular Therapy for Acute Ischemic Stroke with Large Infarct366
SARS-CoV-2 Variants in Patients with Immunosuppression360
Trial of Endovascular Thrombectomy for Large Ischemic Strokes359
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19359
Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia359
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH358
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease358
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients356
Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection352
SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3349
Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer348
Hypothermic Machine Perfusion in Liver Transplantation — A Randomized Trial347
Efficacy of Wolbachia-Infected Mosquito Deployments for the Control of Dengue347
Endovascular Therapy for Stroke Due to Basilar-Artery Occlusion346
Atopic Dermatitis342
Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS342
Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination340
Genetically Modified Porcine-to-Human Cardiac Xenotransplantation339
Biologic Therapies for Severe Asthma339
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19338
Belzutifan for Renal Cell Carcinoma in von Hippel–Lindau Disease337
Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants337
Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants334
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk334
Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron334
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis333
Wildfires, Global Climate Change, and Human Health333
Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death332
Pulmonary Arterial Hypertension330
Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer328
Plasma Neutralization of the SARS-CoV-2 Omicron Variant327
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition326
The Clinician and Dataset Shift in Artificial Intelligence325
SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination324
Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant324
Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion322
Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar322
Maintaining Safety with SARS-CoV-2 Vaccines322
A Randomized Trial Comparing Antibiotics with Appendectomy for Appendicitis321
SARS-CoV-2 Variants and Vaccines318
Current Causes of Death in Children and Adolescents in the United States316
Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma316
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer315
Covid-19 Vaccines — Immunity, Variants, Boosters314
Population Immunity and Covid-19 Severity with Omicron Variant in South Africa312
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1312
Physical Rehabilitation for Older Patients Hospitalized for Heart Failure311
Long-Term Survival after Kidney Transplantation307
A Pandemic within a Pandemic — Intimate Partner Violence during Covid-19307
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma306
Trial of Endovascular Treatment of Acute Basilar-Artery Occlusion305
Protection by a Fourth Dose of BNT162b2 against Omicron in Israel302
Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial301
Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2301
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis300
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico295
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk294
Circadian Mechanisms in Medicine294
Sotatercept for the Treatment of Pulmonary Arterial Hypertension293
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis293
Effect of Vaccination on Household Transmission of SARS-CoV-2 in England290
Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults290
Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome289
Transcatheter Repair for Patients with Tricuspid Regurgitation289
Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants284
Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission284
Women Physicians and Promotion in Academic Medicine284
Long-Term Complications in Youth-Onset Type 2 Diabetes283
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis282
Childhood Cardiovascular Risk Factors and Adult Cardiovascular Events281
Multisystem Inflammatory Syndrome in Children — Initial Therapy and Outcomes280
New Horizons in the Treatment of Osteosarcoma280
Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents279
A Randomized Trial of Intravenous Alteplase before Endovascular Treatment for Stroke279
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis277
0.086023092269897